INDO US BIOTECH Financial Statement Analysis
|
||
The Revenues of INDO US BIOTECH have increased by 23.36% YoY .
The Earnings Per Share (EPS) of INDO US BIOTECH has increased by 26.44 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
INDO US BIOTECH Last 5 Annual Financial Results
[BOM: 541304]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹62 Cr | ₹50 Cr | ₹40 Cr | ₹40 Cr | ₹35 Cr |
Expenses | ₹52 Cr | ₹43 Cr | ₹35 Cr | ₹36 Cr | ₹32 Cr |
Operating Profit (Excl OI) | ₹9.39 Cr | ₹6.93 Cr | ₹5.51 Cr | ₹3.96 Cr | ₹3.42 Cr |
Other Income | ₹0.02 Cr | ₹0.18 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.03 Cr |
Interest | ₹1.20 Cr | ₹1.20 Cr | ₹1.18 Cr | ₹0.88 Cr | ₹0.40 Cr |
Depreciation | ₹0.83 Cr | ₹0.42 Cr | ₹0.25 Cr | ₹0.21 Cr | ₹0.24 Cr |
Profit Before Tax | ₹7.39 Cr | ₹5.49 Cr | ₹4.13 Cr | ₹2.86 Cr | ₹2.81 Cr |
Profit After Tax | ₹7.24 Cr | ₹5.24 Cr | ₹5.10 Cr | ₹2.54 Cr | ₹2.09 Cr |
Consolidated Net Profit | ₹7.24 Cr | ₹5.24 Cr | ₹5.10 Cr | ₹2.54 Cr | ₹2.09 Cr |
Earnings Per Share (Rs) | ₹7.22 | ₹5.71 | ₹8.40 | ₹4.18 | ₹4.30 |
PAT Margin (%) | 11.73 | 10.46 | 12.72 | 6.37 | 5.88 |
ROE(%) | 15.51 | 17.34 | 26.87 | 16.74 | 22.21 |
ROCE(%) | 14.62 | 15.86 | 18.30 | 16.65 | 20.35 |
Total Debt/Equity(x) | 0.21 | 0.32 | 0.53 | 0.52 | 0.45 |
Key Financials |
||
Market Cap | : | ₹ 454.3 Cr |
Revenue (TTM) | : | ₹ 72.6 Cr |
Net Profit(TTM) | : | ₹ 9.1 Cr |
EPS (TTM) | : | ₹ 4.5 |
P/E (TTM) | : | 49.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
INDO US BIOTECH | -2.2% | 6.2% | 252.6% |
BOMBAY BURMAH TRADING CORPORATION | -0.2% | 0.4% | 63.8% |
KAVERI SEED COMPANY | 15.8% | 38.5% | 70.7% |
VENKYS (INDIA) | 1.4% | 13.2% | 17.8% |
BOMBAY SUPER HYBRID SEEDS | -1.6% | 6.1% | -38.7% |
TIERRA AGROTECH | 3.9% | 15.8% | -41.6% |
NATH BIOGENES (INDIA) | 4.6% | 16.9% | 31.2% |
MANGALAM SEEDS | 2.8% | 7.3% | 38.7% |
SHREE OSWAL SEEDS AND CHEMICALS | 5.8% | -6.9% | -49.4% |
INDO US BIOTECH Revenues
[BOM: 541304]
Y-o-Y | 23.36 % |
5 Yr CAGR | 14.85 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹62 Cr | 23.36 | |
Mar2022 | ₹50 Cr | 24.86 | |
Mar2021 | ₹40 Cr | 0.82 | |
Mar2020 | ₹40 Cr | 12.03 | |
Mar2019 | ₹35 Cr | - |
INDO US BIOTECH Operating Profit
[BOM: 541304]
Y-o-Y | 35.52 % |
5 Yr CAGR | 28.73 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹9.39 Cr | 35.52 | |
Mar2022 | ₹6.93 Cr | 25.70 | |
Mar2021 | ₹5.51 Cr | 39.10 | |
Mar2020 | ₹3.96 Cr | 15.91 | |
Mar2019 | ₹3.42 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 9.82 % |
5 Yr CAGR | 12.08 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 15.21% | 9.82 | |
Mar2022 | 13.85% | 0.65 | |
Mar2021 | 13.76% | 38.01 | |
Mar2020 | 9.97% | 3.42 | |
Mar2019 | 9.64% | - |
INDO US BIOTECH Profit After Tax
[BOM: 541304]
Y-o-Y | 38.25 % |
5 Yr CAGR | 36.46 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹7.24 Cr | 38.25 | |
Mar2022 | ₹5.24 Cr | 2.73 | |
Mar2021 | ₹5.10 Cr | 101.10 | |
Mar2020 | ₹2.54 Cr | 21.41 | |
Mar2019 | ₹2.09 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 12.14 % |
5 Yr CAGR | 18.84 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 11.73 % | 12.14 | |
Mar2022 | 10.46 % | -17.77 | |
Mar2021 | 12.72 % | 99.69 | |
Mar2020 | 6.37 % | 8.33 | |
Mar2019 | 5.88 % | - |
INDO US BIOTECH Earnings Per Share (EPS)
[BOM: 541304]
Y-o-Y | 26.44 % |
5 Yr CAGR | 13.83 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹7.22 | 26.44 | |
Mar2022 | ₹5.71 | -32.02 | |
Mar2021 | ₹8.40 | 100.96 | |
Mar2020 | ₹4.18 | -2.79 | |
Mar2019 | ₹4.30 | - |
INDO US BIOTECH Return on Capital Employed (ROCE)
[BOM: 541304]
Y-o-Y | -7.82 % |
5 Yr CAGR | -7.93 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 14.62% | -7.82 | |
Mar2022 | 15.86% | -13.33 | |
Mar2021 | 18.3% | 9.91 | |
Mar2020 | 16.65% | -18.18 | |
Mar2019 | 20.35% | - |
INDO US BIOTECH Share Price vs Sensex
Current Share Price | : | ₹226.0 |
Current MarketCap | : | ₹ 454.3 Cr |
Updated EOD on | : | Apr 29,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -2.2% |
6.2% |
252.6% |
SENSEX | 1.4% |
2.5% |
24.3% |
INDO US BIOTECH related INDICES
You may also like the below Video Courses
FAQ about INDO US BIOTECH Financials
How the annual revenues of INDO US BIOTECH have changed ?
The Revenues of INDO US BIOTECH have increased by 23.36% YoY .
How the Earnings per Share (EPS) of INDO US BIOTECH have changed?
The Earnings Per Share (EPS) of INDO US BIOTECH has increased by 26.44 % YoY .
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs